The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Immunotherapy is a biological therapy and type of targeted treatment that boosts the patient’s natural defence, the immune system, and enables it to find and destroy cancer cells found in the body. At Rutherford Cancer Centres, we use several different types of immunotherapy in the treatment of cancer, in order to prevent cells growing and replicating or spreading around the body.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Dr John Staffurth is a Consultant Clinical Oncologist specialising in urological oncology. His clinical base is at Velindre Cancer Centre and the University Hospital of Wales and his academic base is at Cardiff University where he is Reader in Oncology in Professor Malcolm Mason’s research group.
He trained at Guy's Hospital, qualified in 1992 and started clinical oncology training in 1996. He moved to the Royal Marsden in 1999 and joined the Academic Urology Unit in 2000 taking an MD in IMRT in Pelvic Malignancies at the Institute of Cancer Research.
Dr Staffurth's current research interests are technical radiotherapy for bladder and prostate cancer, and all other aspects of prostate cancer, specifically management of castrate refractory disease states and the immunology of prostate cancer. He leads the introduction of both IMRT and IGRT at Velindre Cancer Centre.
Dr John Staffurth does not hold a share or financial interest in the Rutherford Cancer Centres or another Proton Partners International company.
Dr John Staffurth does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Proton Partners International company.
Dr John Staffurth does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Proton Partners International.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or